LifeCell Reports Fourth Quarter and Full Year 2007 Financi...(sands except for per share data) .....),Health
Navigation Links
LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008
sands, except for
per share data)
December 31,
Selected Balance Sheet Data: 2007 2006
Cash, cash equivalents and
investments $97,922 $77,846
Receivables, net of allowance 25,734 22,286
Inventories 44,267 23,801
Accounts Payable & accrued
liabilities 45,796 27,822
Working Capital 128,331 94,711
Total Assets 216,998 157,121
Total debt obligations - -
Total stockholders' equity 171,202 129,299
'/>"/>
| SOURCE LifeCell Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
2. AMN Healthcare Reports Fourth Quarter and Year End 2007 Results; Provides Full Year 2008 Guidance
3. DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
4. Claimsnet.com Reports Fiscal Year 2007 Results
5. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
6. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
7. 012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. NHP Reports Fourth Quarter and Full Year 2007 Earnings
10. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
11. Clarity for Consumers on Botox Complication and Death Reports
Post Your Comments:
Breaking Medicine News(10 mins):Health News:More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year 2Health News:Clinical trial advances new approach to re-sensitizing breast cancer 2Health News:Study shows how gene action may lead to diabetes prevention, cure 2Health News:Better Vaccine Planning Needed, Committee Finds 2Health News:Better Vaccine Planning Needed, Committee Finds 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4
[0] More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year[0] Clinical trial advances new approach to re-sensitizing breast cancer[0] Study shows how gene action may lead to diabetes prevention, cure[0] Better Vaccine Planning Needed, Committee Finds[0] Effort to Regenerate Injured Spinal Cords Turns to a New Model
Other Medicine News:Health News:Julie Gallagher Joins Akerman Senterfitt's Healthcare Practice 2Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 2Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 3Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 4Health News:Frost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement Advantages 5Health News:Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009 2Health News:DURECT to Participate in Cowen and Company Healthcare Conference 2Health News:More Vitamin C May Mean Less Chance of Gout 2Health News:Study: Doctor-patient conversations at end of life associated with lower medical expenses 2
Julie Gallagher Joins Akerman Senterfitt's Healthcare PracticeFrost & Sullivan Recognizes ValveXchange's Pioneering Heart Valve Technology for Unique Long-term Management and Future Replacement AdvantagesMedivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009DURECT to Participate in Cowen and Company Healthcare ConferenceMore Vitamin C May Mean Less Chance of GoutStudy: Doctor-patient conversations at end of life associated with lower medical expenses
Breaking Medicine Technology:Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 2Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 3Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 4Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 5American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 1American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 2American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 3American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 4Parents of Children With Autism Report High Stress Levels 52016 1Parents of Children With Autism Report High Stress Levels 52016 2Parents of Children With Autism Report High Stress Levels 52016 3New Five Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 52012 1New Five Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 52012 2New Five Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 52012 3New Five Question Test Helps Assess Asthma Control In Children Under Five Years Of Age 52012 4
[0] Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies[0] Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site[0] Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg
Other Medicine Technology:Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |